During the past decade, Ain Wazein Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ain Wazein Hospital" are "Behçet's Syndrome" (1 trials), "Carcinoma, Hepatocellular" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Ain Wazein Hospital" in a lesser frequency.

Most popular intervention types in "Ain Wazein Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (1 trials), "Best Standard of Care" (1 trials), "Doxorubicin 20 mg/m2" (1 trials), "Doxorubicin 30 mg/m2" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ain Wazein Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ain Wazein Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ain Wazein Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ain Wazein Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".